BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua W, Zhang G, Guo S, Li W, Sun L, Xiang G. Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection. Braz J Infect Dis. 2015;19:291-295. [PMID: 25982306 DOI: 10.1016/j.bjid.2015.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Ramesh M, Anand K, Shahbaaz M, Abdellattif MH. Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19. Front Mol Biosci 2021;8:648232. [PMID: 34322517 DOI: 10.3389/fmolb.2021.648232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Duraisamy GS, Bhosale D, Lipenská I, Huvarova I, Růžek D, Windisch MP, Miller AD. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going? Viruses 2020;12:E998. [PMID: 32906840 DOI: 10.3390/v12090998] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Reta DH, Tessema TS, Ashenef AS, Desta AF, Labisso WL, Gizaw ST, Abay SM, Melka DS, Reta FA. Molecular and Immunological Diagnostic Techniques of Medical Viruses. Int J Microbiol 2020;2020:8832728. [PMID: 32908530 DOI: 10.1155/2020/8832728] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
4 Parreira R. Laboratory Methods in Molecular Epidemiology: Viral Infections. Microbiol Spectr 2018;6. [PMID: 30387412 DOI: 10.1128/microbiolspec.AME-0003-2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang X, Li M, Xi H, Zhang R, Chen J, Zhang Y, Xu X. Pre-existing mutations related to tenofovir in chronic hepatitis B patients with long-term nucleos(t)ide analogue drugs treatment by ultra-deep pyrosequencing. Oncotarget. 2016;7:70264-70275. [PMID: 27602500 DOI: 10.18632/oncotarget.11840] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Dunbar S, Farhang J, Das S, Ali S, Qian H. Solid and Suspension Microarrays for Detection and Identification of Infectious Diseases. Advanced Techniques in Diagnostic Microbiology 2018. [DOI: 10.1007/978-3-319-33900-9_20] [Reference Citation Analysis]
7 Wang LP, Cheng X, Li CY, Dai MJ, Han FZ, Yan XB. Relationship between pre-existing resistance mutations and HBV genotype in patients with HBV related liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2017; 25(10): 891-896 [DOI: 10.11569/wcjd.v25.i10.891] [Reference Citation Analysis]
8 Yuan J, Zhang Y, Yan FT, Zheng X. Association of PRKAA1 gene polymorphisms with chronic hepatitis B virus infection in Chinese Han population. Braz J Infect Dis 2016;20:564-8. [PMID: 27612659 DOI: 10.1016/j.bjid.2016.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Elpaeva EA, Komissarov AB, Pisareva MM, Grudinin MP, Kiselev OI. NEW METHOD FOR DETERMINING HEPATITIS B VIRUS RESISTANCE MUTATIONS M204I/V TO NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B. Russian Journal of Infection and Immunity 2015;5:265-272. [DOI: 10.15789/2220-7619-2015-3-265-272] [Reference Citation Analysis]
10 Gu L, Han Y, Li Y, Zhu T, Song X, Huang Y, Yang F, Guan S, Xie J, Gohda J, Hosoya N, Kawana-Tachikawa A, Liu W, Gao GF, Iwamoto A, Li T, Ishida T. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLoS One 2015;10:e0134539. [PMID: 26288093 DOI: 10.1371/journal.pone.0134539] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]